Breakout Ventures Raises $114M to Fund AI Science Startups
▼ Summary
– Breakout Ventures has raised a $114 million Fund III to invest in early-stage, AI-driven startups in scientific fields like biology and chemistry.
– The fund will invest in at least 20 companies, with individual investments ranging from $500,000 to $5 million, and has already funded three.
– The firm specifically seeks startups that use AI to tackle complex scientific challenges and unlock the potential of biology and chemistry.
– Breakout Ventures originated from a Thiel Foundation grant program, launching in 2016, and has previously raised two other science-focused funds.
– The fund’s limited partners include The Kraft Group and Pinegrove Venture Partners, and it took about 18 months to raise.
A venture capital firm dedicated to the intersection of artificial intelligence and hard science has secured a significant new fund to fuel early-stage innovation. Breakout Ventures has successfully closed its third investment fund, raising a total of $114 million. This capital is specifically earmarked for backing startups that leverage AI to tackle complex challenges in scientific domains like biology and chemistry. The firm’s managing director, Lindy Fishburne, emphasized their mission is to find companies dedicated to “unlocking the complexity of science with AI.”
The firm has already initiated its investment strategy from this new fund, providing capital to three initial companies. Their plan is to support at least twenty startups in total, with individual investments ranging from $500,000 to $5 million. This financial backing is designed to propel early-stage ventures that are applying computational power to accelerate discovery and development in the life sciences and materials sectors.
Breakout Ventures has a distinct origin, having spun out from a grant program associated with the Thiel Foundation. The firm officially launched in 2016 and has a track record of raising dedicated funds for science-driven startups. Their first fund closed at $60 million in 2017, followed by a second fund of $112.5 million in 2021. This latest $114 million fund represents a continued and growing commitment to their core thesis.
According to Fishburne, the firm’s philosophy has remained consistent. “We’ve always been focused on the opportunity for technology to unlock the power of biology and chemistry to solve massive unmet needs and create new markets,” she explained. The process of raising this third fund took approximately eighteen months and attracted capital from a group of limited partners that includes The Kraft Group, Pinegrove Venture Partners, and Cubed Capital.
When evaluating potential investments, Breakout looks for a compelling founder fit. The entrepreneurs they back often come from deep scientific or industry backgrounds. “Breakout founders may be PhDs who developed the science they are commercializing, or they may be emerging from industry where they deeply understand the need and opportunity,” Fishburne noted. The critical factor is identifying the clear and obvious reason why a particular founder or team is uniquely positioned to build their specific company and bring a transformative scientific application to market.
(Source: TechCrunch)
